Search Results for "Pharma New Product Launch India"

10:37 EDT 29th August 2015 | BioPortfolio

Matching Channels

India

India, in the Asian subcontinent is the world’s fourth largest producer of pharmaceuticals, and is thought as one of the most promising biotech markets in the world. Several important steps ...

India ink colloidal carbon stain

Eligard

Eligard® is a hormone compound for the treatment of advanced, hormone-dependent prostate cancer. The active ingredient (leuprolide acetate) significantly reduces the level of the male sex hormon...

Datamonitor - aims to help its clients operating in the pharmaceuticals, healthcare and biotechnology fields, offering world-leading products and services to meet the challenges of this rapidly evolving marketplace

The Datamonitor Group aims to help its clients operating in the pharmaceuticals, healthcare and biotechnology fields, offering world-leading products and services to meet the challenges of this rapi...

Laboratory

Labs are the hub of much of modern medicine, either in the hospital setting processing patients blood tests and other samples, in research institutions at many universities or in the headquarters of...

Matching News

India Plans Park for 50 China Pharmas

Pharma City, a new pharma park intended especially for China pharmas, is being established in India, near Hyderabad. Eventually, the site is expected to house manufacturing facilities for 50 China pha...

Indian government sets up pharma 'made in India' committee

To boost development of pharma sector that sources APIs in India

Cantor ups Flex Pharma price target to $27

Cantor Fitzgerald has raised its price target for Flex Pharma (NASDAQ:FLKS) to $27 from $22 to reflect the pre-launch for the company’s consumer product for exercise associated muscle cramps (EAMC)....

Nutra Pharma Provides Updates on Marketing and Distribution of Nyloxin(R) to India / Nutra Pharma Is Providing an Update on the Company's Efforts to Market and Distribute Their Over-the-Counter (OTC) Pain Reliever, Nyloxin(R) in India

CORAL SPRINGS, FL -- (Marketwired) -- 04/15/15 -- Nutra Pharma Corp. (OTC: NPHC), a biotechnology company that is developing treatments for Adrenomyeloneuropathy (AMN), HIV and Multiple Sclerosis ...

India Plans Pharma Clusters to Cut China API Dependence

India is fast-tracking an exhaustive action plan that aims to cut the local pharma industry’s growing dependence on China for raw materials to eventually reach self-reliance.

Sun Pharma completes Ranbaxy acquisition

Sun Pharma has closed its mega merger deal with Ranbaxy and begun the integration of the two businesses. The combined company is now the fifth-largest generics firm in the world, and makes it the larg...

BIG PICTURE - Epistem's Genedrive India launch is inflection point

Epistem’s green light to launch its flagship Genedrive diagnostic test for killer disease TB in India marks an inflection point for the firm.

BMG Pharma Launches its Antimicrobial Gel in China

BMG Pharma S.r.l. announced the launch of its proprietary product Ialuxid Gel in the People’s Republic of China.Read more about BMG Pharma Launches its Antimicrobial Gel in ChinaComments

Matching PubMed Articles

10 years after implementation of TRIPS obligations in India.

The Patent (Amendment) Act of 2005 enforced after TRIPS raises many issues which hinder growth of Indian pharma companies. To tackle this, Indian pharma companies doubled their R&D expenditure and bec...

Discovery of a novel trimebutine metabolite and its impact on N-desmethyltrimebutine quantification by LC-MS/MS.

Hélène Montpetit has a Bachelor of Science in Biochemistry from the University du Québec at Montreal. For the past 15 years, she has worked in the bioanalysis field in CROs environment as well as i...

THE LAUNCH WINDOW HYPOTHESIS AND THE SPEED-ACCURACY TRADE-OFF IN BASEBALL THROWING (.)

-The speed-accuracy trade-off in throwing has been well described, but its cause is poorly understood. The popular impulse-variability hypothesis lacks relevance to throwing, while the launch window h...

Promoting patient safety in India: Situational analysis and the way forward.

Unsafe healthcare is a well-recognized issue internationally and is attracting attention in India as well. Drawing upon the various efforts that have been made to address this issue in India and abroa...

Biosimilars in India.

Biosimilars have been defined as biotech drugs that have been shown to have comparable quality, safety and efficacy to the original product. The past decade has seen a significant increase in interest...

Search Whole site using Google

Loading

Advertisement
 
Advertisement
 
Advertisement Advertisement